A randomized trial of everolimus‐based quadruple therapy vs standard triple therapy early after lung transplantation-Reference-Cited by-同舟云学术

A randomized trial of everolimus‐based quadruple therapy vs standard triple therapy early after lung transplantation

Published:2019-02-05 Issue:6 Volume:19 Page:1759-1769
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Gottlieb Jens¹²,Neurohr Claus³,Müller‐Quernheim Joachim⁴,Wirtz Hubert⁵,Sill Bjoern⁶,Wilkens Heinrike⁷,Bessa Vasiliki⁸,Knosalla Christoph⁹,Porstner Martina¹⁰,Capusan Carmen¹⁰,Strüber Martin¹¹

Affiliation:

1. Department of Respiratory Medicine Hannover Medical School HannoverGermany

2. Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Member of the German Center for Lung Research (DZL) HannoverGermany

3. Grosshadern Medical Clinic and Policlinic V LMU Munich University Hospital MunichGermany

4. Pulmonology Medical Clinic Freiburg University Hospital FreiburgGermany

5. Internal Medicine/Department of Pneumology Leipzig University Hospital LeipzigGermany

6. Department of Cardiovascular Surgery Hamburg‐Eppendorf University Hospital HamburgGermany

7. Internal Medicine V University Hospital of Saarland Homburg SaarGermany

8. Department of Pneumology Ruhrlandklinik West German Center for Lung Transplantation University Hospital Essen University Duisburg‐Essen Essen Germany

9. Department of Cardiothoracic and Vascular Surgery German Heart Institute Berlin DZHK (German Center for Cardiovascular Research) BerlinGermany

10. Novartis Pharma GmbH NurembergGermany

11. Department of Cardiothoracic Surgery Newark Beth Israel Medical Center Children's Hospital of New Jersey Newark New Jersey

Funder

Novartis Pharma

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15251

Reference34 articles.

1. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report—2017; Focus Theme: Allograft ischemic time

2. Donor management and lung preservation for lung transplantation

3. Future direction of immunosuppression in lung transplantation

4. Immunosuppression in lung transplantation;Scheffert JL;J Thorac Dis,2014

5. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney Biopsy Findings After Lung Transplantation;Kidney International Reports;2024-09

2. Everolimus Treatment for Chronic Lung Allograft Dysfunction in Lung Transplantation;Life;2024-05-08

3. Association between anion gap and the 30-day mortality of patients with ventilator-associated pneumonia: a study of the MIMIC-III database;Journal of Thoracic Disease;2024-05

4. A Modern View of Transplant Immunology and Immunosuppression;Organ and Tissue Transplantation;2024

5. Choice of Medications for Lung Transplantation;Organ and Tissue Transplantation;2024